BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 11293097)

  • 1. [Lamotrigine in refractory partial and general epilepsies].
    Mauri-Llerda JA; Tejero C; Espada F; Iñiguez C; Morales F
    Rev Neurol; 2001 Jan 1-15; 32(1):42-5. PubMed ID: 11293097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ; Rahey SR; Sadler RM
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A; Goa KL
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
    Brodie MJ; Chadwick DW; Anhut H; Otte A; Messmer SL; Maton S; Sauermann W; Murray G; Garofalo EA;
    Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine in absence and primary generalized epilepsies.
    Mikati MA; Holmes GL
    J Child Neurol; 1997 Nov; 12 Suppl 1():S29-37. PubMed ID: 9429128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.
    Farrell K; Connolly MB; Munn R; Peng S; MacWilliam LM
    Pediatr Neurol; 1997 Apr; 16(3):201-5. PubMed ID: 9165509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy.
    Beran RG; Berkovic SF; Dunagan FM; Vajda FJ; Danta G; Black AB; Mackenzie R
    Epilepsia; 1998 Dec; 39(12):1329-33. PubMed ID: 9860069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine and seizure aggravation in severe myoclonic epilepsy.
    Guerrini R; Dravet C; Genton P; Belmonte A; Kaminska A; Dulac O
    Epilepsia; 1998 May; 39(5):508-12. PubMed ID: 9596203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey comparing lamotrigine and vigabatrin in everyday clinical practice.
    Schapel G; Chadwick D
    Seizure; 1996 Dec; 5(4):267-70. PubMed ID: 8952011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy.
    Wong IC; Mawer GE; Sander JW; Lhatoo SD
    Epilepsia; 2001 Oct; 42(10):1354-8. PubMed ID: 11737172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamotrigine: clinical experience in 200 patients with epilepsy with follow-up to four years.
    Buchanan N
    Seizure; 1996 Sep; 5(3):209-14. PubMed ID: 8902923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine.
    Sethi A; Chandra D; Puri V; Mallika V
    Neurol India; 2002 Sep; 50(3):359-63. PubMed ID: 12391470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An active-control trial of lamotrigine monotherapy for partial seizures.
    Gilliam F; Vazquez B; Sackellares JC; Chang GY; Messenheimer J; Nyberg J; Risner ME; Rudd GD
    Neurology; 1998 Oct; 51(4):1018-25. PubMed ID: 9781523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of lamotrigine in female patients].
    Schmitz B; Bergmann L
    Nervenarzt; 2007 Aug; 78(8):912-22. PubMed ID: 16523355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
    Steinhoff BJ; Ueberall MA; Siemes H; Kurlemann G; Schmitz B; Bergmann L;
    Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of add-on treatment with lamotrigine in partial epilepsy.
    Smith D; Baker G; Davies G; Dewey M; Chadwick DW
    Epilepsia; 1993; 34(2):312-22. PubMed ID: 8453943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.